Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus in Prediabetic Patients with Atherosclerotic Cardiovascular Disease
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Ezetimibe/pitavastatin (Primary) ; Rosuvastatin
- Indications Cerebrovascular disorders; Coronary artery disease; Peripheral arterial disorders
- Focus Adverse reactions
- Acronyms AVOID-DM
- 16 Jan 2025 New trial record